Combined Therapeutic Potential of Thymoquinone and Theaflavin Through P13k Pathway Suppression
International Journal of Environmental Sciences · 01.09.2025 · 1201-1210
DOI: 10.64252/r2eq7f11 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Environmental Sciences, online erschienen am 01.09.2025. Verfasst von Keerat Mann und 3 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The synergistic potential of natural phytochemicals in modulating key cancer related pathways offers a promising approach for therapeutic development. This study investigates the combined anti-cancer, anti-inflammatory, and antioxidant effects of Thymoquinone and theaflavin on KB cells.
Methods
Thymoquinone and theaflavin were evaluated individually and in combination (1:1,2:1,1:2) across a concentration range of 1 to 200 µg/mL. Cytotoxicity was assessed by MTT assay, anti-inflammatory activity was measured using Bovine serum albumin method, and antioxidant potential was determined via the DPPH radical scavenging assay. Gene expression analysis of P13K, Akt, mTOR, NF-kB, IL-6, Bcl-2 and BAX was performed using real-time PCR.
Results
Combination treatments, especially at a 1:1 ratio, demonstrated significantly enhanced cytotoxicity, superior inhibition of protein denaturation, and greater DPPH radical scavenging compared to individual compounds. Gene expression analysis revealed strong downregulation of the P13K/Akt/mTOR and NF-kB/IL-6 pathways and a shift toward apoptosis characterised by decreased Bcl-2 and increased BAX expression.
Conclusion
The synergistic interaction between Thymoquinone and theaflavin effectively modulates survival, inflammatory, and apoptotic pathways, offering a promising natural combination strategy for anticancer and anti-inflammatory therapies. Further preclinical investigations are warranted to validate their clinical applicability.
Zitieren
APA
Mann, K., S, S., Martin, T. M., & Kumar, M. S. K. (2025). Combined Therapeutic Potential of Thymoquinone and Theaflavin Through P13k Pathway Suppression. International Journal of Environmental Sciences, 1201-1210. https://doi.org/10.64252/r2eq7f11
Vancouver
Mann K, S S, Martin TM, Kumar MSK. Combined Therapeutic Potential of Thymoquinone and Theaflavin Through P13k Pathway Suppression. International Journal of Environmental Sciences. 2025:1201-1210. doi:10.64252/r2eq7f11
BibTeX
@article{Mann2025,
author = {Mann, Keerat and S, Sangeetha and Martin, Taniya Mary and Kumar, Meenakshi Sundaram Kishore},
title = {Combined Therapeutic Potential of Thymoquinone and Theaflavin Through P13k Pathway Suppression},
journal = {International Journal of Environmental Sciences},
year = {2025},
pages = {1201--1210},
doi = {10.64252/r2eq7f11}
}
EUVIMED